Tool for determining responsiveness to anti‐inflamatory agents

Developed by: Fundación Instituto de Investigación Marqués de Valdecilla


IDIVAL has developed a tool for predicting disease severity or prognosis in inflammatory diseases, including Rheumatoid Arthritis, and/or predicting responsiveness to a treatment with anti‐ inflamatory agents, such as anti‐TNFα agents.

The results has been tested in a cohort of more than 1500 patients at Valdecilla Biomedical Research Institute– IDIVAL.


Therapies for inflammatory diseases.


Estado de protección

A patent application covering this technology has been filed through Spanish patent application P201600636. 

Desired cooperation

IDIVAL would like to talk to companies interested in commercializing this tool or in a research cooperation agreement to develop it.


En desarrollo, Transferible
Health technology:
Biotecnología y Diagnóstico Molecular (proteómica, genómica, etc...), Medicamentos - Farma